Bridgeway Capital Management’s Q32 Bio QTTB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$286K Hold
34,613
– – 0.01% 929
2026
Q2
$441K Buy
34,613
+22,000
+174% +$184K 0.01% 878
2026
Q1
$81K Buy
+12,613
New +$59.9K ﹤0.01% 1150
2023
Q4
– Sell
-10,283
Closed -$217K – 1427
2023
Q3
$217K Buy
10,283
+1,666
+19% +$34K 0.01% 1085
2023
Q2
$137K Sell
8,617
-4,166
-33% -$74.8K ﹤0.01% 1206
2023
Q1
$237K Buy
12,783
+311
+2% +$7.75K 0.01% 1074
2022
Q4
$283K Buy
12,472
+1,389
+13% +$36.9K 0.01% 1002
2022
Q3
$321K Buy
11,083
+5,555
+100% +$227K 0.01% 1017
2022
Q2
$196K Sell
5,528
-2,778
-33% -$94.8K ﹤0.01% 1093
2022
Q1
$454K Buy
+8,306
New +$516K 0.01% 961

Other funds holding QTTB

Bridgeway Capital Management's QTTB Position: Q3 2026 in Review

Bridgeway Capital Management held its Q32 Bio (QTTB) position steady in Q3 2026 at 34,613 shares worth $286K. The position accounts for 0.01% of the portfolio, ranked #929.

Bridgeway Capital Management first reported a position in QTTB in Q1 2022 and has held it in 10 quarters since. The position peaked at $454K in Q1 2022. 106 funds tracked by Wall St. Rank hold QTTB as of Q3 2026.

  • Bridgeway Capital Management held 34,613 shares of Q32 Bio worth $286K as of Q3 2026.
  • Bridgeway Capital Management left its Q32 Bio share count unchanged in Q3 2026.
  • Q32 Bio made up 0.01% of Bridgeway Capital Management's portfolio in Q3 2026, its #929 holding.
  • Bridgeway Capital Management first reported a position in Q32 Bio in Q1 2022 and has held it in 10 quarters since.
  • Bridgeway Capital Management's Q32 Bio position peaked at $454K in Q1 2022.
  • 106 funds tracked by Wall St. Rank held Q32 Bio as of Q3 2026.

Based on Bridgeway Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.